NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance With Nasdaq Continued Listing Rules
NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
Trading Halt: Halt Status Updated at 7:30:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 6:56:51 A.m. ET - Trading Halt: Halt News Pending
NLS Pharmaceutics Looks to Raise $0.79M via Securities Offering
NLS Pharmaceutics Announces Publication Of New Patent Application For Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists With The World Intellectual Property Organization